Bempikibart may help regrow hair in people with alopecia areata.
January 2026 in “International Journal of Innovative Technologies in Social Science” This review reports that ritlecitinib, baricitinib, and deuruxolitinib, all JAK inhibitors, are effective treatments for moderate-to-severe alopecia areata, with differences in selectivity and onset of action, and suggests that emerging biologic therapies may enhance treatment by offering more targeted immune modulation.